Molecular Imaging of ACE2 Expression in Infectious Disease and Cancer.
Zhiyao LiAbbie HassonLasya DaggumatiHanwen ZhangDaniel L J ThorekPublished in: Viruses (2023)
Angiotensin-converting enzyme 2 (ACE2) is a cell-surface receptor that plays a critical role in the pathogenesis of SARS-CoV-2 infection. Through the use of ligands engineered for the receptor, ACE2 imaging has emerged as a valuable tool for preclinical and clinical research. These can be used to visualize the expression and distribution of ACE2 in tissues and cells. A variety of techniques including optical, magnetic resonance, and nuclear medicine contrast agents have been developed and employed in the preclinical setting. Positron-emitting radiotracers for highly sensitive and quantitative tomography have also been translated in the context of SARS-CoV-2-infected and control patients. Together this information can be used to better understand the mechanisms of SARS-CoV-2 infection, the potential roles of ACE2 in homeostasis and disease, and to identify potential therapeutic modulators in infectious disease and cancer. This review summarizes the tools and techniques to detect and delineate ACE2 in this rapidly expanding field.
Keyphrases
- angiotensin converting enzyme
- angiotensin ii
- infectious diseases
- magnetic resonance
- sars cov
- high resolution
- poor prognosis
- papillary thyroid
- end stage renal disease
- cell surface
- respiratory syndrome coronavirus
- binding protein
- ejection fraction
- gene expression
- small molecule
- newly diagnosed
- chronic kidney disease
- cell therapy
- stem cells
- healthcare
- magnetic resonance imaging
- mesenchymal stem cells
- risk assessment
- squamous cell carcinoma
- peritoneal dialysis
- young adults
- cell cycle arrest
- cell death
- fluorescent probe
- quantum dots
- social media
- long non coding rna
- high speed
- energy transfer